BOSTON, Aug. 27, 2019 (GLOBE NEWSWIRE) — LifePod® Solutions Inc., the groundbreaking, proactive-voice caregiving service, has joined the American Heart Association’s Center for Health Technology & Innovation (the Center) Innovators Network to implement a first-of-its-kind heart failure study to support CarePlan adherence among those suffering from chronic heart conditions. The Center is focused […]
Other News
Amarin Provides Overview on Growing Global Attention on REDUCE-IT™ Results and Cardiovascular Risk Management Beyond Cholesterol Management
Multiple Papers and Presentations Highlight REDUCE-IT and Vascepa® Potential Mechanisms of Action of Vascepa Becoming Better Understood American Heart Association References REDUCE-IT in Scientific Advisory BEDMINSTER, N.J. and DUBLIN, Ireland, Aug. 27, 2019 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, today provided […]
DiA Imaging Analysis Partnered With Edan Instruments to Accelerate the Adoption of DiA’s AI-based Cardiac Ultrasound Solutions
BE’ER SHEVA, Israel, and SHENZEN, China, Aug. 27, 2019 /PRNewswire/ — DiA Imaging Analysis Ltd. (DiA), a leading provider of artificial intelligence (AI)-powered ultrasound analysis solutions, announced a partnership with Edan Instruments Inc., a leading medical products and services company. Ultrasound is a $7B market rapidly growing, adding new users in various point-of-care settings. Yet, acquiring the […]
ZOLL Medical Completes Acquisition of Cardiac Science
Expands Solutions for Cardiac Arrest Victims in the Community CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today confirmed that it has completed the previously announced acquisition of Cardiac Science® Corporation, a leading provider of automated external defibrillators (AEDs), related […]
EBR Systems Closes $30M in New Funding, John McCutcheon Joins Company as President and CEO
SUNNYVALE, Calif., Aug. 27, 2019 /PRNewswire/ — EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced it has closed $30M in new funding to complete enrollment of its pivotal SOLVE CRT clinical trial and to prepare for commercialization of the WiSE Cardiac Resynchronization Therapy (CRT) System. This […]
AtriCure Receives Clearance for Expanded Labeling Claims for AtriClip Devices
Clinical evidence demonstrates that AtriClip® devices exclude and electrically isolate the left atrial appendage MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatment for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of […]
First-ever: FDA Clears Biobeat’s Wearable Watch and Patch for Non-invasive Cuffless Monitoring of Blood Pressure
TEL AVIV, Israel, Aug. 26, 2019 /PRNewswire/ — Biobeat, a bio-medical technology company developing advanced sensing and remote monitoring solutions for patients, announced today that the U.S. Food and Drug Administration (FDA) has granted a 510K clearance for its patch and watch for measurement of blood pressure, oxygenation and heart rate in hospitals, clinics, long-term […]
Avinger Announces Proposed Underwritten Public Offering of Common Stock
REDWOOD CITY, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced that it intends to offer shares of its common stock for sale in an underwritten public offering. In addition, the Company expects to grant […]
Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
VANCOUVER, Aug. 22, 2019 /PRNewswire/ – (“Neovasc” or the “Company”) (NASDAQ:NVCN)(TSX:NVCN), announced today that it has received written notification (the “Notification Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum market value requirement set forth in Nasdaq Rules for continued listing on […]
Medicure Announces Settlement of Patent Infringement Action
WINNIPEG, Aug. 21, 2019 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, today announces that its subsidiary, Medicure International Inc., has settled its ongoing patent infringement action against Gland Pharma Ltd. (“Gland”) in the U.S. District Court for the District of New Jersey, which alleged infringement of […]



